N4 Pharma Plc (LON:N4P – Get Free Report) was up 9.1% during mid-day trading on Tuesday . The stock traded as high as GBX 0.60 ($0.01) and last traded at GBX 0.60 ($0.01). Approximately 658,522 shares traded hands during mid-day trading, a decline of 37% from the average daily volume of 1,052,872 shares. The stock had previously closed at GBX 0.55 ($0.01).
N4 Pharma Stock Up 9.1 %
The stock’s 50 day moving average is GBX 0.54 and its 200 day moving average is GBX 0.62. The company has a market capitalization of £2.37 million, a PE ratio of -60.00 and a beta of -0.37. The company has a debt-to-equity ratio of 1.62, a quick ratio of 7.28 and a current ratio of 14.86.
N4 Pharma Company Profile
N4 Pharma Plc, a specialist pharmaceutical company, develops silica nanoparticle delivery system for pharmaceutical and biotechnology companies in the United Kingdom. It develops Nuvec, a non-viral adjuvant delivery system for vaccines and cancer treatments. N4 Pharma Plc was incorporated in 1979 and is based in London, the United Kingdom.
Further Reading
- Five stocks we like better than N4 Pharma
- Using the MarketBeat Stock Split Calculator
- The Average 401k Balance by Age Explained
- 3 Tickers Leading a Meme Stock Revival
- 3 Uranium Stocks To Gain as Microsoft Goes Nuclear to Power AI
- The Significance of a Trillion-Dollar Market Cap Goes Beyond a Number
- Biotech Boom Ahead? Key Stocks and ETFs to Watch Now
Receive News & Ratings for N4 Pharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for N4 Pharma and related companies with MarketBeat.com's FREE daily email newsletter.
